Try Calculator
← Back to Compound Library HORMONES / REPRODUCTIVE

HMG (Human Menopausal Gonadotropin)

The Dual Gonadotropin for Complete Fertility Support and Hormonal Restoration Human Menopausal Gonadotropin (HMG) is a hormonal medication containing both follicle- stimulating hormone (FSH) and luteinizing hormone (LH) activity. It is extracted from the urine of postmenopausal women, whose naturally elevated gonadotropin levels provide a source of these hormones. Unlike HCG, which only mimics LH, HMG provides both FSH and LH stimulation in approximately a 1:1 ratio. This makes HMG particularly valuable for fertility applications where both hormones are needed to support complete reproductive function. In men, FSH is essential for spermatogenesis (sperm production), while LH stimulates testosterone production. Because exogenous testosterone and even HCG alone can suppress FSH, adding HMG or recombinant FSH becomes necessary when full fertility preservation or restoration is the goal. HMG was first introduced clinically in 1961 and has been a cornerstone of fertility medicine ever since. Brand names include Pergonal, Menopur, Repronex, and Merional. While recombinant gonadotropins have largely replaced HMG in many fertility clinics, HMG remains valuable, particularly for male fertility protocols. For men on testosterone replacement therapy (TRT) who want to maintain or restore fertility, HMG added to HCG provides more complete gonadal support than HCG alone.

How HMG Works (Mechanism of Action) HMG provides direct stimulation to the gonads through both FSH and LH pathways. Understanding the role of each hormone is essential for understanding why HMG is more comprehensive than HCG alone.

FSH Activity

FSH acts on Sertoli cells in the testes to:

Without adequate FSH, sperm production decreases or ceases entirely.

LH Activity

LH acts on Leydig cells in the testes to:

Why Both Matter

Spermatogenesis requires both testosterone from Leydig cells (LH-dependent) and Sertoli cell support (FSH-dependent). HCG alone provides LH-like activity but no FSH stimulation. For men with suppressed FSH (such as those on TRT or recovering from anabolic steroid use), HCG maintains testosterone but may not fully restore sperm production. HMG fills this gap by providing FSH activity alongside LH activity.

Clinical Application in Male Fertility

In male fertility protocols, the typical approach follows a stepwise process: 1. HCG is started first to restore testosterone production. 2. If sperm counts do not recover after 4 to 6 months on HCG alone, HMG or recombinant FSH is added. 3. The combination addresses both hormonal pathways necessary for spermatogenesis.

Benefits

Complete Gonadotropin Support

HMG provides what HCG cannot:

Fertility Restoration

For men with suppressed spermatogenesis:

Hypogonadotropic Hypogonadism Treatment

For men with pituitary or hypothalamic dysfunction:

Superior to HCG Alone for Fertility

When fertility is the primary goal:

What the Science Shows

HMG has decades of clinical use with substantial evidence supporting its role in male fertility.

MacLeod et al. (1960s) — Early Landmark Studies

This early foundational work demonstrated:

pituitary)

Büchter et al. (1998), European Journal of Endocrinology — Review of 42

Cases

This study reviewed HCG/HMG treatment outcomes in men with hypogonadotropic hypogonadism:

Lee et al. (2018), Translational Andrology and Urology — Clinical Guidelines This review provided clinical recommendations for HMG use in male fertility:

to 6 months

Lunenfeld (2004), Human Reproduction Update — Historical Perspectives This comprehensive review traced the history of gonadotropin therapy from the initial discovery through modern clinical applications, documenting the pivotal role HMG has played in reproductive medicine since its introduction in 1961.

Comparison Studies: HMG Versus Recombinant FSH

Studies comparing HMG with recombinant FSH for male fertility have found:

Dosing Protocol

HMG dosing for men is typically added to an existing HCG protocol when FSH support is needed.

Understanding the Dose Context

HMG is measured in International Units (IU). Standard vials contain 75 IU of FSH activity and 75 IU of LH activity per ampoule. Because men on HMG are usually also taking HCG (which provides LH activity), the primary benefit comes from the FSH component.

Standard Male Protocol

Setting Dose Frequency Notes With HCG (starting) 75 IU 3 times weekly Standard starting dose Increased dose 150 IU 3 times weekly If no response at 4 months Maximum dose 225 IU 3 times weekly Rarely needed

Typical Combined Protocol

Phase Medication Dose Notes Weeks 1 to 24 HCG alone 1,500–2,000 IU Establish testosterone

3x/week

Week 24 onward Add HMG 75 IU 3x/week If sperm count inadequate

Hypogonadotropic Hypogonadism Protocol

For men without prior testicular priming:

Duration Expectations

Draw Volumes by Vial Size

75 IU Vial (1 mL reconstitution = 75 IU/mL)

Dose Volume 75 IU (full vial) 1.0 mL 37.5 IU (half vial) 0.5 mL

For doses requiring multiple vials per injection, reconstitute all vials with the same diluent (using the solution from the first vial to dissolve subsequent vials).

Reconstitution Instructions

HMG typically comes as lyophilized powder with diluent provided: 1. Remove the plastic cap from both the HMG vial and the diluent vial. 2. Wipe both rubber stoppers with alcohol swabs. 3. Draw 1 mL of diluent into a syringe. 4. Inject the diluent into the HMG powder vial. 5. Swirl gently until dissolved. Do not shake vigorously. 6. If using multiple vials, draw the reconstituted solution and use it to dissolve the next vial. 7. Draw the final solution into the injection syringe.

HMG should be used immediately after reconstitution. Unlike some peptides, it is typically not stored after mixing.

Side Effects

Common Side Effects

Hormonal Effects

Serious Concerns (Primarily in Women)

In Men

HMG is generally well tolerated at recommended doses. Breast tenderness may indicate the need for dose adjustment or the addition of an aromatase inhibitor. Estradiol levels should be monitored, particularly when HMG is combined with HCG.

Contraindications and Precautions

Should Avoid

Use with Care

Comparison to Similar Compounds

Compound FSH Activity LH Activity Primary Use Route HMG Yes Yes Fertility restoration SubQ or IM HCG No Yes (mimics) TRT adjunct, SubQ or IM testosterone Recombinant Yes No Fertility (pure FSH) SubQ

FSH

Gonadorelin Stimulates Stimulates TRT adjunct, pulsatile SubQ Kisspeptin Stimulates Stimulates TRT adjunct, research SubQ

HMG Versus HCG

HCG provides LH-like activity only. HMG provides both FSH and LH. For fertility, HMG (or recombinant FSH) is often added to HCG when sperm production needs support. HCG alone is sufficient for maintaining testosterone production but is often insufficient for restoring full spermatogenesis.

HMG Versus Recombinant FSH

Recombinant FSH (such as Gonal-F) provides pure FSH without LH activity. When used with HCG, the effect is similar to HMG. The choice often depends on cost, availability, and physician preference. HMG may be more cost-effective, while recombinant FSH offers more precise dosing of the FSH component.

Success Tips

Be Patient

Spermatogenesis takes time. A single sperm cycle is approximately 70 days, and meaningful improvements may take multiple cycles. Do not expect immediate results. Plan for 6 to 12 months at minimum.

Combine Appropriately

HMG is most effective when combined with HCG:

Monitor Progress

Regular semen analyses (every 3 to 4 months) track the treatment response. Blood work for FSH, LH, testosterone, and estradiol helps optimize dosing.

Foundation Matters

Even with hormonal support, sperm production requires:

Injection Technique

HMG can be administered subcutaneously or intramuscularly. Subcutaneous injection is generally preferred for convenience and comfort. Some protocols specify intramuscular injection into the deltoid or gluteal muscle. Both routes are considered effective.

Storage and Handling

Before Reconstitution

After Reconstitution

HMG is typically supplied in single-dose vials intended for immediate use after reconstitution.

Legal Status

United States: HMG is a prescription medication FDA approved for fertility treatment. Brand names include Menopur, Repronex, and Pergonal. It is available through pharmacies with a prescription. International: Generally available with a prescription for fertility indications.

Frequently Asked Questions

Why would I need HMG if I am already taking HCG? HCG provides LH-like stimulation but no FSH activity. FSH is essential for spermatogenesis. If FSH is suppressed (from TRT or anabolic steroids) and sperm production is not recovering with HCG alone, adding HMG provides the FSH stimulation the testes need. How is HMG different from recombinant FSH? HMG contains both FSH and LH activity extracted from human urine. Recombinant FSH (such as Gonal-F) is pure FSH produced through genetic engineering. When combined with HCG, both approaches provide similar results. HMG may be more cost-effective.

How long until I see results? Spermatogenesis takes approximately 70 days per cycle. Meaningful improvements in sperm count may take 3 to 6 months. Maximum sperm production can take 12 to 24 months of consistent therapy. Can HMG replace testosterone therapy? In men with secondary hypogonadism (pituitary or hypothalamic dysfunction), HMG combined with HCG can restore natural testosterone production. It is not effective for primary hypogonadism (testicular failure). Most men use HMG as an adjunct for fertility rather than as primary testosterone therapy. Is HMG the same as FSH? HMG contains FSH activity but also includes LH activity. If already taking HCG (which provides LH activity), the FSH component of HMG is the primary benefit. Some protocols use recombinant FSH instead for this reason. Can HMG be used for women? Yes. HMG has been used extensively in female fertility medicine for ovarian stimulation in assisted reproductive technology. However, this article focuses on male applications. Female use requires close medical supervision due to the risk of ovarian hyperstimulation syndrome (OHSS).

References

1. Lunenfeld B. Historical perspectives in gonadotropin therapy. Human Reproduction Update. 2004;10(6):453-467. 2. Lee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Translational Andrology and Urology. 2018;7(Suppl 3):S348-S352. 3. Büchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology. 1998;139(3):298-303. 4. Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. Journal of Urology. 2014;192(3):875-879. 5. Nieschlag E, Behre HM, Nieschlag S. Andrology: Male Reproductive Health and Dysfunction. 3rd ed. Berlin: Springer; 2010.

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.

Get In Touch